Volume 22 Issue 1
Jan.  2024
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2024  >  22(1): 154-157
LIU Haoyu, PENG Wenjia, MI Jing, JIA Xianjie, ZHANG Yuyuan. APC analysis of the global disease burden of Parkinson's disease from 1990 to 2019[J]. Chinese Journal of General Practice, 2024, 22(1): 154-157. doi: 10.16766/j.cnki.issn.1674-4152.003353
Citation: LIU Haoyu, PENG Wenjia, MI Jing, JIA Xianjie, ZHANG Yuyuan. APC analysis of the global disease burden of Parkinson's disease from 1990 to 2019[J]. Chinese Journal of General Practice, 2024, 22(1): 154-157. doi: 10.16766/j.cnki.issn.1674-4152.003353
shu

APC analysis of the global disease burden of Parkinson's disease from 1990 to 2019

doi: 10.16766/j.cnki.issn.1674-4152.003353
  • 1.

    School of Public Health, Bengbu Medical University, Bengbu, Anhui 233030, China

Funds:

 KJ2021A0710

 2020byzd044

  • Received Date: 2023-06-19
    Available Online: 2024-03-09
    Abstract
  •   Objective  Analysis of the trends in the global disease burden of Parkinson's disease from 1990-2019 and to explore the impact of age, period, and cohort on the risk of developing the disease burden of Parkinson's disease.  Methods  By collecting and analyzing the global disease burden of Parkinson's disease from 1990 to 2019, the Joinpoint regression model was used to analyze the trend of the disease burden of Parkinson's disease, and the age-period-cohort model (APC model) was used to analyze the age, period and cohort effects of the disease burden of Parkinson's disease.  Results  The global standard disability-adjusted life years (DALY) rate for Parkinson's disease showed no overall trend from 1990 to 2019 (P>0.05), the standard DALY rate (per 100 000 population) of males and females increased and decreased, respectively. The standard DALY rate of males increased from 102.86 to 106.44, with an annual average increase rate of 0.119% [average annual percentage change (AAPC)=0.119, t=2.559, P=0.010]. The normalized DALY rate (per 100 000 population) in females decreased from 61.61 to 59.91, with an annual average rate of 0.097% (AAPC=-0.097, t=2.565, P=0.010). Results of the APC model showed that the age effect of DALY rate risk of PD increased first and then decreased with increasing age during 1990-2019 (P < 0.05). The period effect increased with the increase of year (P < 0.05). The cohort effect decreased with the progression of the birth cohort (P < 0.05).  Conclusion  From 1990 to 2019, there was no change in the global disease burden of Parkinson's disease, Males showed an upward trend and females showed a downward trend. The risk of disease burden increased first and then decreased with the increase of age, increased with the increase of years, and decreased with the increase of birth cohort. Prevention efforts should be strengthened in special groups such as the elderly. Reducing the future global burden of Parkinson's disease.

     

    • FullText(HTML)
  • loading
    • References(15)
  • [1]
    赵亚军, 田久鹏, 王德强, 等. 上海市社区全科医生对帕金森病的诊断认知及影响因素分析[J]. 中华全科医学, 2022, 20(5): 808-811. doi: 10.16766/j.cnki.issn.1674-4152.002460

    ZHAO Y J, TIAN J P, WANG D Q, et al. Diagnosis cognition and influencing factors of Parkinson disease among community general practitioners in Shanghai[J]. Chinese Journal of General Practice, 2022, 20(5): 808-811. doi: 10.16766/j.cnki.issn.1674-4152.002460
    [2]
    GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2019, 18(5): 459-480. doi: 10.1016/S1474-4422(18)30499-X
    [3]
    ELSWORTH J D. Parkinson's disease treatment: past, present, and future[J]. J Neural Transm (Vienna), 2020, 127(5): 785-791. doi: 10.1007/s00702-020-02167-1
    [4]
    丁贤彬, 吕晓燕, 毛德强, 等. 2010—2017年重庆市宫颈癌疾病负担变化趋势分析[J]. 中国肿瘤, 2019, 28(9): 657-662. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201909005.htm

    DING X B, LV X Y, MAO D Q, et al. Trend Analysis of Disease Burden of Cervical Cancer from 2010 to 2017 in Chongqing[J]. China Cancer, 2019, 28(9): 657-662. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201909005.htm
    [5]
    罗丽莎, 栾航航, 朱聪, 等. 1990—2019年中国、日本与韩国的良性前列腺增生疾病负担比较[J]. 现代泌尿外科杂志, 2023, 28(6): 506-512. https://www.cnki.com.cn/Article/CJFDTOTAL-MNWK202306010.htm

    LUO L S, LUAN H H, ZHU C, et al. Disease burden of benign prostatic hyperplasia in China, Japan and South Korea from 1990 to 2019: a comparative study[J]. Journal of Modern Urology, 2023, 28(6): 506-512. https://www.cnki.com.cn/Article/CJFDTOTAL-MNWK202306010.htm
    [6]
    GBD. Global health data exchange[EB]. (2019-08-11)[2023-05-20]. http://ghdx.healthdata.org/gbd-results-tool.
    [7]
    曾四清. Joinpoint回归模型及其在传染病流行趋势分析中的应用[J]. 中国卫生统计, 2019, 36(5): 787-791. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201905044.htm

    ZENG S Q. Joinpoint regression model and its application in the analysis of epidemic trend of infectious diseases[J]. Chinese Journal of Health Statistic, 2019, 36(5): 787-791. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201905044.htm
    [8]
    RAJAN S, KAAS B. Parkinson's disease: risk factor modification and prevention[J]. Semin Neurol, 2022, 42(5): 626-638. doi: 10.1055/s-0042-1758780
    [9]
    CERRI S, MUS L, BLANDINI F. Parkinson's disease in women and men: what's the difference?[J]. J Parkinsons Dis, 2019, 9(3): 501-515.
    [10]
    BRAKEDAL B, TOKER L, HAUGARVOLL K, et al. A nationwide study of the incidence, prevalence and mortality of Parkinson's disease in the Norwegian population[J]. NPJ Parkinsons Dis, 2022, 8(1): 19.
    [11]
    BOULOS C, YAGHI N, EL HAYECK R, et al. Nutritional risk factors, microbiota and Parkinson's disease: what is the current evidence?[J]. Nutrients, 2019, 11(8): 1896. doi: 10.3390/nu11081896
    [12]
    张硕, 高健, 姜立刚. 帕金森病患病率及相关因素的流行病学研究现状[J]. 吉林医药学院学报, 2021, 42(6): 437-439. https://www.cnki.com.cn/Article/CJFDTOTAL-JLDS202106016.htm

    ZHANG S, GAO J, JIANG L G. Current status of epidemiological studies on the prevalence and related factors of Parkinson's disease[J]. Journal of Jilin Medical College, 2021, 42(6): 437-439. https://www.cnki.com.cn/Article/CJFDTOTAL-JLDS202106016.htm
    [13]
    黄荣, 李晓晖, 陈文武. 帕金森病患者危险因素分析[J]. 罕少疾病杂志, 2022, 29(6): 17-19. https://www.cnki.com.cn/Article/CJFDTOTAL-HSJB202206006.htm

    HUANG R, LI X H, CHEN W W. Analysis of Risk Factors in Patients with Parkinson's Disease[J]. Journal of Rare and Uncommon Diseases, 2022, 29(6): 17-19. https://www.cnki.com.cn/Article/CJFDTOTAL-HSJB202206006.htm
    [14]
    周桃峰, 周志明. 帕金森病的诊断与治疗[J]. 中华全科医学, 2019, 17(12): 1982-1983. http://www.zhqkyx.net/article/id/70de6dad-4539-43a9-9096-481d8db02a44

    ZHOU T F, ZHOU Z M. Diagnosis and treatment of Parkinson's disease[J]. Chinese Journal of General Practice, 2019, 17(12): 1982-1983. http://www.zhqkyx.net/article/id/70de6dad-4539-43a9-9096-481d8db02a44
    [15]
    YASUHARA T. Neurobiology research in Parkinson's disease[J]. Int J Mol Sci, 2020, 21(3): 793.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (200) PDF downloads(8) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return